Skip to content
Catalyst

erythritolWhat was measured

Measured, with no finding

754 endpoints

Show what was measuredHide what was measured
  • A. actinomycetemcomitans (AA) study sites >100,000 cells/ml

    no effect

    AA >1000; >100,000 | 7; 1 | 7; 0 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • A. actinomycetemcomitans (AA) study sites >100,000 cells/ml

    no effect

    AA >1000; >100,000 | 3; 0 | 10; 2 | 0.035; n.s.

    PMID 25041441 · one of two readings recorded this

  • A. actinomycetemcomitans (AA) study sites >1000 cells/ml

    no effect

    AA >1000; >100,000 | 7; 1 | 7; 0 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • A. actinomycetemcomitans (AA) study sites >1000 cells/ml

    decreases, p = 0.035

    AA >1000; >100,000 | 3; 0 | 10; 2 | 0.035; n.s.

    PMID 25041441 · one of two readings recorded this

  • B. forsythia (BF) study sites >100,000 cells/ml

    no effect

    BF >1000; >100,000 | 37; 20 | 39; 15 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • B. forsythia (BF) study sites >100,000 cells/ml

    no effect

    BF >1000; >100,000 | 35; 18 | 35; 19 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • B. forsythia (BF) study sites >1000 cells/ml

    no effect

    BF >1000; >100,000 | 37; 20 | 39; 15 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • B. forsythia (BF) study sites >1000 cells/ml

    no effect

    BF >1000; >100,000 | 35; 18 | 35; 19 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • bleeding on probing (BOP+), deepest study site

    no effect

    BOP+, % | 58 (50) | 48 (50) | n.s.

    PMID 25041441 · one of two readings recorded this

  • bleeding on probing (BOP+), deepest study site

    no effect

    BOP+, % | 31 (47) | 27 (45) | n.s.

    PMID 25041441 · one of two readings recorded this

  • bleeding on probing (BOP+)

    no effect

    BOP+, % | 22 (10) | 21 (10) | n.s.

    PMID 25041441 · one of two readings recorded this

  • bleeding on probing (BOP+)

    no effect

    BOP+, % | 15 (6) | 14 (6) | n.s.

    PMID 25041441 · one of two readings recorded this

  • gingival recession (REC), deepest study site

    no effect

    REC, mm | 1.0 (0.9) | 0.9 (1.0) | n.s.

    PMID 25041441 · one of two readings recorded this

  • gingival recession (REC), deepest study site

    no effect

    REC, mm | 1.0 (1.0) | 0.8 (1.1) | n.s.

    PMID 25041441 · one of two readings recorded this

  • gingival recession (REC)

    no effect

    REC, mm | 0.9 (0.7) | 0.9 (0.7) | n.s.

    PMID 25041441 · one of two readings recorded this

  • gingival recession (REC)

    no effect

    REC, mm | 0.9 (0.7) | 0.9 (0.7) | n.s.

    PMID 25041441 · one of two readings recorded this

  • number of residual pockets with PD >4 mm per subject at 12 months, primary endpoint

    no effect

    Not recorded as a finding: the intervention held more than the compound

    Compared to baseline the mean number of pockets >4 mm per subject was significantly lower with both protocols (p < 0.001); the difference between groups was not significant (primary outcome).

    PMID 25041441 · one of two readings recorded this

  • number of sites with PD >4 mm per patient

    no effect

    n sites with PD >4 mm | 4.6 (5.6) | 4.8 (5.2) | n.s.

    PMID 25041441 · one of two readings recorded this

  • number of sites with PD >4 mm per patient

    no effect

    n sites with PD >4 | 3.6 (5.8) | 3.9 (6.2) | n.s.

    PMID 25041441 · one of two readings recorded this

  • operator time for subgingival debridement of all sites >4 mm

    hand-piece back, was 1.5 ± 1.4 min per person

    PMID 25041441 · one of two readings recorded this

  • operator time for subgingival debridement of all sites >4 mm

    the control side was, 1.7 ± 1.5 min

    PMID 25041441 · one of two readings recorded this

  • P. gingivalis (PG) study sites >100,000 cells/ml

    no effect

    PG >1000; >100,000 | 37; 14 | 37; 12 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • P. gingivalis (PG) study sites >100,000 cells/ml

    no effect

    PG >1000; >100,000 | 33; 9 | 34; 10 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • P. gingivalis (PG) study sites >1000 cells/ml

    no effect

    PG >1000; >100,000 | 37; 14 | 37; 12 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • P. gingivalis (PG) study sites >1000 cells/ml

    no effect

    PG >1000; >100,000 | 33; 9 | 34; 10 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • P. intermedia (PI) study sites >100,000 cells/ml

    no effect

    PI >1000; >100,000 | 20; 8 | 14; 6 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • P. intermedia (PI) study sites >100,000 cells/ml

    no effect

    PI >1000; >100,000 | 17; 4 | 11; 4 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • P. intermedia (PI) study sites >1000 cells/ml

    no effect

    PI >1000; >100,000 | 20; 8 | 14; 6 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • P. intermedia (PI) study sites >1000 cells/ml

    no effect

    PI >1000; >100,000 | 17; 4 | 11; 4 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • P. micra (PM) study sites >100,000 cells/ml

    no effect

    PM >1000; >100,000 | 44; 19 | 49; 23 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • P. micra (PM) study sites >100,000 cells/ml

    no effect

    PM >1000; >100,000 | 41; 19 | 41; 16 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • P. micra (PM) study sites >1000 cells/ml

    no effect

    PM >1000; >100,000 | 44; 19 | 49; 23 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • P. micra (PM) study sites >1000 cells/ml

    no effect

    PM >1000; >100,000 | 41; 19 | 41; 16 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • pain during treatment (VAS 1 to 100 mm), between-arm difference

    decreases, p = 0.004

    air-polishing was statistically significant (p = 0.004)

    PMID 25041441 · one of two readings recorded this

  • pain during treatment (VAS 1 to 100 mm)

    on a VAS from 1 to 100 mm, was 20.4 ± 21.7 mm for the test and

    PMID 25041441 · one of two readings recorded this

  • pain during treatment (VAS 1 to 100 mm)

    48.6 ± 29.2 mm for the control treatment

    PMID 25041441 · one of two readings recorded this

  • persisting pockets with probing depth >4 mm at 12 months (primary), probing depth, bleeding on probing, recession, root hypersensitivity VAS, treatment pain VAS, and six subgingival bacteria by qPCR, test side subgingival air-polishing versus control side ultrasonic debridement

    p = 0.004, n = 50

    Not recorded as a finding: the intervention held more than the compound

    The difference in favour of air-polishing was statistically significant (p = 0.004).

    PMID 25041441 · one of two readings recorded this

  • plaque index (PlI)

    no effect

    PlI, score 0–3 | 0.4 (0.2) | 0.4 (0.2) | n.s.

    PMID 25041441 · one of two readings recorded this

  • plaque index (PlI)

    no effect

    PlI, score 0–3 | 0.3 (0.1) | 0.3 (0.1) | n.s.

    PMID 25041441 · one of two readings recorded this

  • probing depth (PD), deepest study site

    unclear, p = 0.003

    PD, mm | 5.2 (0.4) | 5.4 (0.6) | 0.003

    PMID 25041441 · one of two readings recorded this

  • probing depth (PD), deepest study site

    no effect

    PD, mm | 4.5 (1.0) | 4.4 (1.1) | n.s.

    PMID 25041441 · one of two readings recorded this

  • probing depth (PD)

    no effect

    PD, mm | 2.8 (0.3) | 2.8 (0.3) | n.s.

    PMID 25041441 · one of two readings recorded this

  • probing depth (PD)

    no effect

    PD, mm | 2.8 (0.5) | 2.7 (0.5) | n.s.

    PMID 25041441 · one of two readings recorded this

  • root hypersensitivity, deepest study site

    no effect

    Root hypersensitivity, mm VAS | 22.2 (27.4) | 21.2 (21.2) | n.s.

    PMID 25041441 · one of two readings recorded this

  • root hypersensitivity, deepest study site

    no effect

    Root hypersensitivity, mm VAS | 21.3 (23.0) | 16.6 (17.8) | n.s.

    PMID 25041441 · one of two readings recorded this

  • T. denticola (TD) study sites >100,000 cells/ml

    no effect

    TD >1000; >100,000 | 42; 22 | 42; 27 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • T. denticola (TD) study sites >100,000 cells/ml

    no effect

    TD >1000; >100,000 | 36; 21 | 38; 17 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • T. denticola (TD) study sites >1000 cells/ml

    no effect

    TD >1000; >100,000 | 42; 22 | 42; 27 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • T. denticola (TD) study sites >1000 cells/ml

    no effect

    TD >1000; >100,000 | 36; 21 | 38; 17 | n.s.; n.s.

    PMID 25041441 · one of two readings recorded this

  • bacterial species detectable in the pocket sulcus (Maximo 2009, bicarbonate air-abrasive)

    decreases

    The authors reported a significant reduction of a number of bacterial species detectable in the pocket sulcus

    PMID 26065025 · one of two readings recorded this

  • baseline probing depth at implant 2.5 (case report)

    The clinical assessment allowed finding a probing depth of 14 mm mesial/circumferentially to 2.5 with bleeding

    PMID 26065025 · one of two readings recorded this

  • clinical parameters and inflammatory cytokines (prospective study of 20 implants, bicarbonate air-abrasive)

    decreases

    At 3 months, all clinical parameters improved as the presence of inflammatory cytokines reduced

    PMID 26065025 · one of two readings recorded this

  • gingival index and probing depth (Toma, glycine powder air-polishing)

    decreases

    Gingival index and probing depth significantly improved in cases treated with glycine powder

    PMID 26065025 · one of two readings recorded this

  • implant failures after follow-up (Behneke 2000, bicarbonate air-polishing with GBR)

    unclear

    After three years of follow-up, two failures were reported

    PMID 26065025 · one of two readings recorded this

  • implants and patients treated (Behneke 2000)

    n = 25

    Behneke and coworkers reported data on 25 implants in 17 patients with signs and symptoms of peri-implantitis

    PMID 26065025 · one of two readings recorded this

  • postsurgical complications (case report)

    no effect

    No complications occurred in the postsurgical period

    PMID 26065025 · one of two readings recorded this

  • stability of bone graft and reosseointegration (case report)

    unclear

    Both clinical and radiographic examination confirmed a substantial stability of bone graft that allowed hypothesizing the reosseointegration of the implant affected by peri-implantitis

    PMID 26065025 · one of two readings recorded this

  • total amount of TNF-a (case series 2009, sodium carbonate air-powder)

    decreases

    Moreover, the total amount of TNF-a significantly reduced over time

    PMID 26065025 · one of two readings recorded this

  • bone sounding (BS) at baseline

    no effect, p = 0.222

    BS base (mm) | 7.00 ± 0.96 | 7.27 ± 0.82 | 0.222

    PMID 32839833 · one of two readings recorded this

  • bone sounding (BS)

    no effect, p = 0.916

    12 m (mm) | 4.00 ± 0.94S | 4.04 ± 0.75S | 0.916

    PMID 32839833 · one of two readings recorded this

  • bone sounding (BS)

    no effect, p = 0.422

    6 m (mm) | 4.14 ± 0.72S | 3.88 ± 0.94S | 0.422

    PMID 32839833 · one of two readings recorded this

  • bone sounding gain (ΔBS)

    no effect, p = 0.71

    ΔBS base-12 m (mm) | 3.11 ± 1.16 | 3.21 ± 0.75 | 0.710

    PMID 32839833 · one of two readings recorded this

  • bone sounding gain (ΔBS)

    no effect, p = 0.247

    ΔBS base-6 m (mm) | 2.86 ± 1.17 | 3.42 ± 1.26 | 0.247

    PMID 32839833 · one of two readings recorded this

  • CAL gain (ΔCAL)

    no effect, p = 0.266

    ΔCAL base-12 m (mm) | 2.50 ± 1.60 | 2.85 ± 1.21 | 0.266

    PMID 32839833 · one of two readings recorded this

  • CAL gain (ΔCAL)

    no effect, p = 0.469

    ΔCAL base-6 m (mm) | 2.00 ± 1.80 | 2.5 ± 1.26 | 0.469

    PMID 32839833 · one of two readings recorded this

  • clinical attachment level (CAL) at baseline

    no effect, p = 0.8

    CAL base (mm) | 7.87 ± 1.25 | 8.03 ± 1.54 | 0.800

    PMID 32839833 · one of two readings recorded this

  • clinical attachment level (CAL)

    no effect, p = 0.921

    12 m (mm) | 5.43 ± 1.91S | 5.38 ± 1.94S | 0.921

    PMID 32839833 · one of two readings recorded this

  • clinical attachment level (CAL)

    no effect, p = 0.73

    6 m (mm) | 5.86 ± 2.14S | 5.54 ± 2.15S | 0.730

    PMID 32839833 · one of two readings recorded this

  • full-mouth bleeding on probing (BOP) at baseline

    no effect, p = 1

    BOP base (%) | 13.06 ± 13.97 | 11.94 ± 10.78 | 1.000

    PMID 32839833 · one of two readings recorded this

  • full-mouth bleeding on probing (BOP)

    no effect, p = 0.685

    12 m (%) | 12.91 ± 12.55 | 14.21 ± 13.42 | 0.685

    PMID 32839833 · one of two readings recorded this

  • full-mouth bleeding on probing (BOP)

    no effect, p = 0.381

    6 m (%) | 11.83 ± 7.32 | 10.71 ± 6.71 | 0.381

    PMID 32839833 · one of two readings recorded this

  • full-mouth bleeding on probing, gingival bleeding index and full-mouth plaque score, baseline to 6 and 12 months

    no effect, p > 0.05

    Not recorded as a finding: The only sentence mixes within-arm change over time with the between-group comparison and names the patients, not the compound; full-mouth BOP in a periodontal surgery trial at one tooth is not a clean between-arm contrast

    Patients maintained good oral hygiene (FMPS) and low levels of inflammation (BOP; GBI) without statistically significant changes between baseline and 6 or 12 months respectively or between the two treatment groups (p > 0.05) (Table 3).

    PMID 32839833 · one of two readings recorded this

  • full-mouth gingival bleeding index (GBI) at baseline

    no effect, p = 0.983

    GBI base (%) | 5.57 ± 8.15 | 4.89 ± 6.85 | 0.983

    PMID 32839833 · one of two readings recorded this

  • full-mouth gingival bleeding index (GBI)

    no effect, p = 0.666

    12 m (%) | 4.92 ± 6.80 | 4.13 ± 5.84 | 0.666

    PMID 32839833 · one of two readings recorded this

  • full-mouth gingival bleeding index (GBI)

    no effect, p = 0.123

    6 m (%) | 5.54 ± 10.05 | 3.03 ± 7.36 | 0.123

    PMID 32839833 · one of two readings recorded this

  • full-mouth plaque score (FMPS) at baseline

    no effect, p = 0.455

    FMPS base (%) | 23.34 ± 13.14 | 19.36 ± 13.06 | 0.455

    PMID 32839833 · one of two readings recorded this

  • full-mouth plaque score (FMPS)

    no effect, p = 0.356

    12 m (%) | 17.57 ± 9.86 | 23.22 ± 14.08 | 0.356

    PMID 32839833 · one of two readings recorded this

  • full-mouth plaque score (FMPS)

    no effect, p = 0.299

    6 m (%) | 21.85 ± 9.58 | 20.26 ± 16.48 | 0.299

    PMID 32839833 · one of two readings recorded this

  • PD reduction (ΔPD)

    no effect, p = 0.24

    ΔPD base-12 m (mm) | 3.00 ± 0.96 | 3.38 ± 1.12 | 0.240

    PMID 32839833 · one of two readings recorded this

  • PD reduction (ΔPD)

    no effect, p = 0.309

    ΔPD base-6 m (mm) | 3.00 ± 0.78 | 3.35 ± 1.11 | 0.309

    PMID 32839833 · one of two readings recorded this

  • pocket closure (PD ≤ 3 mm), percentage of patients

    no effect

    At 12 months, a comparable percentage of patients showed “pocket closure” (PD ≤ 3 mm): 78.57% (n = 11) in the test group and 76.92% (n = 10) in the control group

    PMID 32839833 · one of two readings recorded this

  • probing depth (PD) and PD reduction, bone sounding, radiographic bone level at 12 months

    no effect, p > 0.05

    Not recorded as a finding: No node for periodontal probing depth (peri-implant-probing-depth is implant-only), bone sounding or radiographic bone level; the CAL gain sentence names them only in a bracket

    There were no statistically significant differences between the two treatment groups neither for CAL gain (p = 0.469/0.266 for 6/12 months) nor for any of the other evaluated clinical parameters at the two evaluated timepoints (p > 0.05, PD, AL, BS).

    PMID 32839833 · one of two readings recorded this

  • probing pocket depth (PD) at baseline

    unclear, p = 0.035

    PD base (mm) | 6.00 ± 0.00 | 6.23 ± 0.42 | 0.035s

    PMID 32839833 · one of two readings recorded this

  • probing pocket depth (PD)

    no effect, p = 0.456

    12 m (mm) | 3.07 ± 0.92S | 2.85 ± 0.99S | 0.456

    PMID 32839833 · one of two readings recorded this

  • probing pocket depth (PD)

    no effect, p = 0.675

    6 m (mm) | 3.00 ± 0.78S | 2.92 ± 0.86S | 0.675

    PMID 32839833 · one of two readings recorded this

  • radiographic bone level (BL) at baseline

    no effect, p = 0.917

    BL base (mm) | 8.06 ± 2.82 | 7.68 ± 2.01 | 0.917

    PMID 32839833 · one of two readings recorded this

  • radiographic bone level (BL)

    no effect, p = 0.433

    12 m (mm) | 5.91 ± 2.02S | 6.52 ± 2.41S | 0.433

    PMID 32839833 · one of two readings recorded this

  • radiographic bone level gain (ΔBL)

    no effect, p = 0.075

    ΔBL (mm) | 2.27 ± 1.52 | 1.30 ± 1.04 | 0.075

    PMID 32839833 · one of two readings recorded this

  • bleeding on probing (BOP, %) at six sites per tooth, manual probe at 0.25 N, 6 months after subgingival instrumentation with or without adjunctive erythritol air-polishing (primary outcome); also PD, CAL, sites with PD >= 5 mm, plaque index, bacterial counts, GCF MMP-8 and IL-1 beta

    no effect, no difference between groups, n = 42

    Not recorded as a finding: the supporting sentence never names the compound

    The means of PD, AL and BOP were significantly improved in both groups three and six months after SI (p < 0.01, p < 0.001) without any difference between the groups.

    PMID 33372602 · one of two readings recorded this

  • bleeding on probing (BOP), mean PD and attachment level, between groups

    no effect

    The means of PD, AL and BOP were significantly improved in both groups three and six months after SI (p < 0.01, p < 0.001) without any difference between the groups

    PMID 33372602 · one of two readings recorded this

  • bleeding on probing (BOP, %) six months after subgingival instrumentation, primary outcome, six-point measurement per tooth with a manual probe at 0.25 N

    no effect

    Not recorded as a finding: the supporting sentence never names the compound

    The means of PD, AL and BOP were significantly improved in both groups three and six months after SI (p < 0.01, p < 0.001) without any difference between the groups.

    PMID 33372602 · one of two readings recorded this

  • bleeding on probing (BOP)

    decreases

    Control group | 27.9 ± 16.5 | 13.9 ± 9.6*** | 12.0 ± 9.2***

    PMID 33372602 · one of two readings recorded this

  • bleeding on probing (BOP)

    decreases

    Control group | 27.9 ± 16.5 | 13.9 ± 9.6*** | 12.0 ± 9.2***

    PMID 33372602 · one of two readings recorded this

  • bleeding on probing (BOP)

    decreases

    Test group | 28.8 ± 31.6 | 13.5 ± 7.5** | 11.5 ± 4.6**

    PMID 33372602 · one of two readings recorded this

  • bleeding on probing (BOP)

    decreases

    Test group | 28.8 ± 31.6 | 13.5 ± 7.5** | 11.5 ± 4.6**

    PMID 33372602 · one of two readings recorded this

  • IL-1β in gingival crevicular fluid

    no effect

    The levels of IL-1β did not change, neither in the test nor in the control groups

    PMID 33372602 · one of two readings recorded this

  • interproximal plaque index (API)

    no effect

    Control group | 24.3 ± 20.7 | 19.7 ± 20.7 | 14.8 ± 9.6*

    PMID 33372602 · one of two readings recorded this

  • interproximal plaque index (API)

    decreases

    Control group | 24.3 ± 20.7 | 19.7 ± 20.7 | 14.8 ± 9.6*

    PMID 33372602 · one of two readings recorded this

  • interproximal plaque index (API)

    no effect

    Test group | 16.9 ± 9.7 | 15.9 ± 17.7 | 16.4 ± 14.4

    PMID 33372602 · one of two readings recorded this

  • interproximal plaque index (API)

    no effect

    Test group | 16.9 ± 9.7 | 15.9 ± 17.7 | 16.4 ± 14.4

    PMID 33372602 · one of two readings recorded this

  • mean clinical attachment level (CAL)

    decreases

    Control group | 3.52 ± 0.44 | 3.05 ± 0.44*** | 3.02 ± 0.45**

    PMID 33372602 · one of two readings recorded this

  • mean clinical attachment level (CAL)

    decreases

    Control group | 3.52 ± 0.44 | 3.05 ± 0.44*** | 3.02 ± 0.45**

    PMID 33372602 · one of two readings recorded this

  • mean clinical attachment level (CAL)

    decreases

    Test group | 3.50 ± 0.45 | 2.94 ± 0.50*** | 2.85 ± 0.42***

    PMID 33372602 · one of two readings recorded this

  • mean clinical attachment level (CAL)

    decreases

    Test group | 3.50 ± 0.45 | 2.94 ± 0.50*** | 2.85 ± 0.42***

    PMID 33372602 · one of two readings recorded this

  • mean probing depth (PD)

    decreases

    Control group | 3.08 ± 0.36 | 2.46 ± 0.35*** | 2.30 ± 0.26***

    PMID 33372602 · one of two readings recorded this

  • mean probing depth (PD)

    decreases

    Control group | 3.08 ± 0.36 | 2.46 ± 0.35*** | 2.30 ± 0.26***

    PMID 33372602 · one of two readings recorded this

  • mean probing depth (PD)

    decreases

    Test group | 3.14 ± 0.39 | 2.44 ± 0.42*** | 2.23 ± 0.25***

    PMID 33372602 · one of two readings recorded this

  • mean probing depth (PD)

    decreases

    Test group | 3.14 ± 0.39 | 2.44 ± 0.42*** | 2.23 ± 0.25***

    PMID 33372602 · one of two readings recorded this

  • MMP-8 in gingival crevicular fluid

    no effect

    The levels of MMP-8 in the GCF decreased in the test group, they were significantly less at six months when compared with baseline, in the control group there was no change

    PMID 33372602 · one of two readings recorded this

  • MMP-8 in gingival crevicular fluid

    decreases

    The levels of MMP-8 in the GCF decreased in the test group, they were significantly less at six months when compared with baseline, in the control group there was no change

    PMID 33372602 · one of two readings recorded this

  • number of sites with PD ≥ 5 mm, between groups

    decreases, p = 0.019

    The number of sites with PD ≥ 5 mm was significantly lower in the test group than in the control group after six months (p = 0.019)

    PMID 33372602 · one of two readings recorded this

  • number of sites with PD ≥ 5 mm

    decreases

    Control group | 27.62 ± 6.54 | 6.54 ± 8.37*** | 3.12 ± 4.02***¶¶

    PMID 33372602 · one of two readings recorded this

  • number of sites with PD ≥ 5 mm

    decreases

    Control group | 27.62 ± 6.54 | 6.54 ± 8.37*** | 3.12 ± 4.02***¶¶

    PMID 33372602 · one of two readings recorded this

  • number of sites with PD ≥ 5 mm

    decreases

    Test group | 29.88 ± 15.27 | 4.16 ± 7.68*** | 0.64 ± 1.38***

    PMID 33372602 · one of two readings recorded this

  • number of sites with PD ≥ 5 mm

    decreases

    Test group | 29.88 ± 15.27 | 4.16 ± 7.68*** | 0.64 ± 1.38***

    PMID 33372602 · one of two readings recorded this

  • Porphyromonas gingivalis counts

    decreases

    P. gingivalis counts were decreased in the control group at three months versus baseline

    PMID 33372602 · one of two readings recorded this

  • Tannerella forsythia and Treponema denticola counts

    decreases

    The counts of T. forsythia and T. denticola were found to be reduced at six months versus baseline in the test group

    PMID 33372602 · one of two readings recorded this

  • bleeding on probing (BoP), patient level

    decreases, p = 0.001

    BoP | 54.2 ± 4.1 | 38.4 ± 4.1 | 35.6 ± 4.1 | 32.3 ± 4.1 | 25.3 ± 4.1 | − 18.7 ± 3.3 | < 0.001 | − 10.3 ± 3.3 | 0.002 | − 28.9 ± 3.3 | < 0.001

    PMID 33478480 · one of two readings recorded this

  • clinical attachment level at furcation sites, 6 and 12 months, erythritol versus ultrasonic/curette

    decreases, 0.8 mm difference at 6 months in favour of control (p = 0.032); 0.6 mm at 12 months (p = 0.097), p = 0.032

    Not recorded as a finding: the between-arm sentence does not name CAL, so the object cannot be anchored in the quote; the sentences that name CAL are within-arm gains

    At 6 months there was a significant between-treatment difference of 0.8 mm (± 0.4) in favor of the control (p = 0.032), a tendency also observed at 12 months (0.6 mm ± 0.4; p = 0.097).

    PMID 33478480 · one of two readings recorded this

  • clinical attachment level at furcation sites, test versus control, 6 and 12 months (primary outcome)

    decreases, 0.8 mm (+/- 0.4) at 6 months in favor of control; 0.6 mm (+/- 0.4) at 12 months, p = 0.097

    Not recorded as a finding: The only between-arm sentence gives a significant difference favouring control at 6 months and a non-significant tendency at 12 months, with no sentence stating the 12-month absence in words; it also does not name the compound, and CAL level is not the CAL gain node's change-from-baseline quantity

    At 6 months there was a significant between-treatment difference of 0.8 mm (± 0.4) in favor of the control (p = 0.032), a tendency also observed at 12 months (0.6 mm ± 0.4; p = 0.097).

    PMID 33478480 · one of two readings recorded this

  • clinical attachment level (CAL), furcation site, between-treatment difference

    no effect, p = 0.097

    Difference | 0.5 ± 0.4 | 0.221 | 0.8 ± 0.4 | 0.032 | 0.6 ± 0.4 | 0.097 | 0.3 ± 0.2 | 0.107 | − 0.2 ± 0.2 | 0.404 | 0.2 ± 0.2 | 0.448

    PMID 33478480 · one of two readings recorded this

  • clinical attachment level (CAL), furcation site, between-treatment difference

    increases, p = 0.032

    Difference | 0.5 ± 0.4 | 0.221 | 0.8 ± 0.4 | 0.032 | 0.6 ± 0.4 | 0.097 | 0.3 ± 0.2 | 0.107 | − 0.2 ± 0.2 | 0.404 | 0.2 ± 0.2 | 0.448

    PMID 33478480 · one of two readings recorded this

  • clinical attachment level (CAL), furcation site

    no effect, p = 0.119

    Test | 5.5 ± 0.4 | 5.2 ± 0.4 | 5.1 ± 0.4 | − 0.3 ± 0.2 | 0.175 | − 0.1 ± 0.2 | 0.502 | − 0.4 ± 0.3 | 0.119

    PMID 33478480 · one of two readings recorded this

  • clinical attachment level (CAL), furcation site

    no effect, p = 0.175

    Test | 5.5 ± 0.4 | 5.2 ± 0.4 | 5.1 ± 0.4 | − 0.3 ± 0.2 | 0.175 | − 0.1 ± 0.2 | 0.502 | − 0.4 ± 0.3 | 0.119

    PMID 33478480 · one of two readings recorded this

  • clinical attachment level (CAL), furcation site

    decreases, p = 0.004

    Control | 5.0 ± 0.2 | 4.4 ± 0.3 | 4.5 ± 0.3 | − 0.6 ± 0.1 | < 0.001 | 0.1 ± 0.1 | 0.584 | − 0.5 ± 0.2 | 0.004

    PMID 33478480 · one of two readings recorded this

  • clinical attachment level (CAL), furcation site

    decreases, p = 0.001

    Control | 5.0 ± 0.2 | 4.4 ± 0.3 | 4.5 ± 0.3 | − 0.6 ± 0.1 | < 0.001 | 0.1 ± 0.1 | 0.584 | − 0.5 ± 0.2 | 0.004

    PMID 33478480 · one of two readings recorded this

  • clinical attachment level (CAL), patient level

    decreases, p = 0.001

    CAL | 4.0 ± 0.2 | 3.7 ± 0.2 | 3.6 ± 0.2 | 3.5 ± 0.2 | 3.5 ± 0.2 | − 0.3 ± 0.0 | < 0.001 | − 0.2 ± 0.0 | < 0.001 | − 0.5 ± 0.1 | < 0.001

    PMID 33478480 · one of two readings recorded this

  • furcation-site probing depth, test versus control, 6 and 12 months (primary outcome)

    no effect, no significant between-treatment differences

    Not recorded as a finding: No node for periodontal probing depth; the sentence is also agentless about the compound

    No significant between-treatment differences were observed for any timepoint.

    PMID 33478480 · one of two readings recorded this

  • furcation sites showing BoP

    decreases

    At baseline, all sites (100%, inclusion criteria) showed BoP, whereas at 6 months the number decreased to 70% and 90%, and at 12 months to 68% and 53% for test and control sites, respectively

    PMID 33478480 · one of two readings recorded this

  • furcation sites showing BoP

    decreases

    At baseline, all sites (100%, inclusion criteria) showed BoP, whereas at 6 months the number decreased to 70% and 90%, and at 12 months to 68% and 53% for test and control sites, respectively

    PMID 33478480 · one of two readings recorded this

  • furcation sites with visible plaque

    At baseline, 63% of the test furcation sites and 53% of the control furcation sites showed visible plaque following staining

    PMID 33478480 · one of two readings recorded this

  • furcation sites with visible plaque

    By 6 months, the corresponding observations were 40% and 45%, and at 12 months 50% and 44%

    PMID 33478480 · one of two readings recorded this

  • furcation sites with visible plaque

    By 6 months, the corresponding observations were 40% and 45%, and at 12 months 50% and 44%

    PMID 33478480 · one of two readings recorded this

  • gingival crevicular fluid (GCF) volume, furcation site, between-treatment difference

    no effect, p = 0.917

    Difference | 0.7 ± 8.8 | 0.937 | 2.2 ± 8.8 | 0.804 | − 1.0 ± 9.1 | 0.917 | − 1.5 ± 12.5 | 0.905 | 3.2 ± 12.7 | 0.804 | 1.7 ± 12.7 | 0.897

    PMID 33478480 · one of two readings recorded this

  • gingival crevicular fluid (GCF) volume, furcation site, between-treatment difference

    no effect, p = 0.804

    Difference | 0.7 ± 8.8 | 0.937 | 2.2 ± 8.8 | 0.804 | − 1.0 ± 9.1 | 0.917 | − 1.5 ± 12.5 | 0.905 | 3.2 ± 12.7 | 0.804 | 1.7 ± 12.7 | 0.897

    PMID 33478480 · one of two readings recorded this

  • gingival crevicular fluid (GCF) volume, furcation site

    decreases, p = 0.001

    Test | 79.5 ± 7.5 | 57.3 ± 7.5 | 44.0 ± 7.7 | − 22.2 ± 11.0 | 0.044 | − 14.6 ± 11.2 | 0.171 | − 36.7 ± 11.2 | 0.001

    PMID 33478480 · one of two readings recorded this

  • gingival crevicular fluid (GCF) volume, furcation site

    decreases, p = 0.044

    Test | 79.5 ± 7.5 | 57.3 ± 7.5 | 44.0 ± 7.7 | − 22.2 ± 11.0 | 0.044 | − 14.6 ± 11.2 | 0.171 | − 36.7 ± 11.2 | 0.001

    PMID 33478480 · one of two readings recorded this

  • gingival crevicular fluid (GCF) volume, furcation site

    decreases, p = 0.001

    Control | 78.8 ± 7.5 | 55.1 ± 7.5 | 45.0 ± 7.7 | − 23.7 ± 7.6 | 0.002 | − 10.6 ± 7.7 | 0.171 | − 34.2 ± 7.7 | < 0.001

    PMID 33478480 · one of two readings recorded this

  • gingival crevicular fluid (GCF) volume, furcation site

    decreases, p = 0.002

    Control | 78.8 ± 7.5 | 55.1 ± 7.5 | 45.0 ± 7.7 | − 23.7 ± 7.6 | 0.002 | − 10.6 ± 7.7 | 0.171 | − 34.2 ± 7.7 | < 0.001

    PMID 33478480 · one of two readings recorded this

  • P. micra and T. denticola, furcation sites positive >10^5

    increases

    P. micra and T. denticola displayed a significant increase from baseline to 6 months for both treatments

    PMID 33478480 · one of two readings recorded this

  • plaque, patient level

    decreases, p = 0.009

    Plaque | 56.1 ± 4.3 | 45.5 ± 4.3 | 46.5 ± 4.5 | 45.6 ± 4.8 | 44.6 ± 5.2 | − 9.6 ± 3.8 | 0.010 | − 1.8 ± 3.8 | 0.629 | − 11.5 ± 4.4 | 0.009

    PMID 33478480 · one of two readings recorded this

  • probing depth of furcation sites and full mouth, periodontal probe PCP UNC 15, six sites per tooth

    no effect

    Not recorded as a finding: no outcome node for probing depth around natural teeth; peri-implant-probing-depth is implants only. The between-arm sentence is agentless

    No significant between-treatment differences were observed for any timepoint.

    PMID 33478480 · one of two readings recorded this

  • probing depth (PD), furcation site, between-treatment difference

    no effect, p = 0.232

    Difference | 0.2 ± 0.3 | 0.468 | 0.5 ± 0.4 | 0.192 | 0.4 ± 0.4 | 0.232 | 0.20 ± 0.3 | 0.454 | − 0.0 ± 0.3 | 0.901 | 0.2 ± 0.3 | 0.540

    PMID 33478480 · one of two readings recorded this

  • probing depth (PD), furcation site, between-treatment difference

    no effect, p = 0.192

    Difference | 0.2 ± 0.3 | 0.468 | 0.5 ± 0.4 | 0.192 | 0.4 ± 0.4 | 0.232 | 0.20 ± 0.3 | 0.454 | − 0.0 ± 0.3 | 0.901 | 0.2 ± 0.3 | 0.540

    PMID 33478480 · one of two readings recorded this

  • probing depth (PD), furcation site

    decreases, p = 0.001

    Test | 4.8 ± 0.4 | 4.0 ± 0.4 | 3.7 ± 0.4 | − 0.9 ± 0.2 | < 0.001 | − 0.2 ± 0.2 | 0.331 | − 1.0 ± 0.2 | < 0.001

    PMID 33478480 · one of two readings recorded this

  • probing depth (PD), furcation site

    decreases, p = 0.001

    Test | 4.8 ± 0.4 | 4.0 ± 0.4 | 3.7 ± 0.4 | − 0.9 ± 0.2 | < 0.001 | − 0.2 ± 0.2 | 0.331 | − 1.0 ± 0.2 | < 0.001

    PMID 33478480 · one of two readings recorded this

  • probing depth (PD), furcation site

    decreases, p = 0.001

    Control | 4.6 ± 0.2 | 3.5 ± 0.3 | 3.4 ± 0.3 | − 1.05 ± 0.2 | < 0.001 | − 0.1 ± 0.2 | 0.534 | − 1.2 ± 0.3 | < 0.001

    PMID 33478480 · one of two readings recorded this

  • probing depth (PD), furcation site

    decreases, p = 0.001

    Control | 4.6 ± 0.2 | 3.5 ± 0.3 | 3.4 ± 0.3 | − 1.05 ± 0.2 | < 0.001 | − 0.1 ± 0.2 | 0.534 | − 1.2 ± 0.3 | < 0.001

    PMID 33478480 · one of two readings recorded this

  • probing depth (PD), patient level

    decreases, p = 0.001

    PD | 3.2 ± 0.1 | 2.9 ± 0.1 | 2.8 ± 0.1 | 2.7 ± 0.1 | 2.7 ± 0.1 | − 0.4 ± 0.0 | < 0.001 | − 0.2 ± 0.0 | 0.094 | − 0.5 ± 0.1 | < 0.001

    PMID 33478480 · one of two readings recorded this

  • proportion of furcation sites with PD ≤ 4 mm (pocket closure)

    increases

    For test sites, the proportion of PD ≤ 4 mm (pocket closure) increased from 60.0% at baseline to 65.0% and 79.0% at 6 and 12 months, respectively

    PMID 33478480 · one of two readings recorded this

  • proportion of furcation sites with PD ≤ 4 mm (pocket closure)

    increases

    For test sites, the proportion of PD ≤ 4 mm (pocket closure) increased from 60.0% at baseline to 65.0% and 79.0% at 6 and 12 months, respectively

    PMID 33478480 · one of two readings recorded this

  • proportion of furcation sites with PD ≤ 4 mm (pocket closure)

    increases

    A corresponding increase was observed for control sites from 60.0% at baseline to 80.0% and 84.2% at 6 and 12 months

    PMID 33478480 · one of two readings recorded this

  • proportion of furcation sites with PD ≤ 4 mm (pocket closure)

    increases

    A corresponding increase was observed for control sites from 60.0% at baseline to 80.0% and 84.2% at 6 and 12 months

    PMID 33478480 · one of two readings recorded this

  • proportion of patient-level PD ≤ 4 mm (pocket closure)

    increases

    The proportion of PD ≤ 4 mm (pocket closure) increased from 87.7% at baseline to 93.1% and 95.1% at 6 and 12 months, respectively

    PMID 33478480 · one of two readings recorded this

  • proportion of patient-level PD ≤ 4 mm (pocket closure)

    increases

    The proportion of PD ≤ 4 mm (pocket closure) increased from 87.7% at baseline to 93.1% and 95.1% at 6 and 12 months, respectively

    PMID 33478480 · one of two readings recorded this

  • total mean number of bacterial species per furcation site, between-treatment difference

    no effect, p = 0.334

    No significant between-treatment differences were detected at baseline (p = 0.523) or at 6 (p = 0.706) and 12 (p = 0.334) months

    PMID 33478480 · one of two readings recorded this

  • total mean number of bacterial species per furcation site, between-treatment difference

    no effect, p = 0.706

    No significant between-treatment differences were detected at baseline (p = 0.523) or at 6 (p = 0.706) and 12 (p = 0.334) months

    PMID 33478480 · one of two readings recorded this

  • total mean number of bacterial species per furcation site, between-treatment difference

    no effect, p = 0.523

    No significant between-treatment differences were detected at baseline (p = 0.523) or at 6 (p = 0.706) and 12 (p = 0.334) months

    PMID 33478480 · one of two readings recorded this

  • total mean number of bacterial species per furcation site

    Total mean numbers of species present in test and control furcation sites at baseline were 1.95 and 2.25, respectively

    PMID 33478480 · one of two readings recorded this

  • total mean number of bacterial species per furcation site

    Corresponding numbers at 6 and 12 months were 3.10, 3.15 and 2.21, 1.76

    PMID 33478480 · one of two readings recorded this

  • total mean number of bacterial species per furcation site

    Corresponding numbers at 6 and 12 months were 3.10, 3.15 and 2.21, 1.76

    PMID 33478480 · one of two readings recorded this

  • treatment discomfort (VAS)

    decreases, p = 0.001

    the erythritol air-polishing system (13.3) compared with conventional mechanical debridement (13.3 vs. 32.6; p = 0.001)

    PMID 33478480 · one of two readings recorded this

  • active GLP-1 iAUC 0-60 min, 0-180 min and iCmax after erythritol versus placebo

    Not recorded as a finding: Node plasma-glp-1 exists, but the sentences give significance with no direction word

    Pairwise comparisons revealed statistically significant differences for 10 g erythritol versus placebo, 25 g erythritol versus placebo, 50 g erythritol versus placebo and for 10 versus 50 g erythritol.

    PMID 33565706 · one of two readings recorded this

  • appetite-related sensations

    no effect

    No effect of erythritol treatment on appetite‐related sensations was found

    PMID 33565706 · one of two readings recorded this

  • blood lipids (total cholesterol, LDL, HDL, triglycerides) and uric acid

    no effect

    There was no statistically significant increase from baseline in blood lipids (total cholesterol, LDL, HDL and triglycerides) or uric acid within 120 min after 50 g erythritol

    PMID 33565706 · one of two readings recorded this

  • correlation of aGLP-1 iAUC 0-60 min with gastric emptying

    decreases

    CCK, aGLP‐1 and PYY were weakly negatively correlated with gastric emptying (R = −0.266, R = −0.145 and R = −0.427, respectively)

    PMID 33565706 · one of two readings recorded this

  • correlation of CCK iAUC 0-60 min with gastric emptying

    decreases

    CCK, aGLP‐1 and PYY were weakly negatively correlated with gastric emptying (R = −0.266, R = −0.145 and R = −0.427, respectively)

    PMID 33565706 · one of two readings recorded this

  • correlation of PYY iAUC 0-60 min with gastric emptying

    decreases

    CCK, aGLP‐1 and PYY were weakly negatively correlated with gastric emptying (R = −0.266, R = −0.145 and R = −0.427, respectively)

    PMID 33565706 · one of two readings recorded this

  • gastric emptying AUC 0-180 min (13C-sodium acetate breath test)

    increases, p = 0.001

    AUC (0‐180 min) (dose*min/h) | 1595.6 ± 252.1 | 2048.4 ± 434.1 | 2052.7 ± 485.3 | 2102.5 ± 259.8 |.001 | 1).035 2).061 3).002

    PMID 33565706 · one of two readings recorded this

  • gastric emptying AUC 0-60 min (13C-sodium acetate breath test)

    modulates, p = 0.009

    AUC (0‐60 min) (dose*min/h) | 896.9 ± 128.1 | 1103.2 ± 185.6 | 1036.9 ± 190.4 | 921.5 ± 107.3 |.009 | 1).026 4).027

    PMID 33565706 · one of two readings recorded this

  • gastric emptying T50%, pairwise

    increases

    the time needed to empty 50% of the dose was significantly longer for 50 g erythritol versus placebo (76.4 ± 12.1 vs. 55.5 ± 17.2 min)

    PMID 33565706 · one of two readings recorded this

  • gastric emptying T50%, pairwise

    increases

    and 50 versus 10 g erythritol (76.4 ± 12.1 vs. 59.8 ± 19.5 min)

    PMID 33565706 · one of two readings recorded this

  • gastric emptying T50% (time 50% emptied)

    increases, p = 0.005

    T50% (time 50% emptied) (min) | 55. 5 ± 17.2 | 59.8 ± 19.5 | 68.1 ± 16.1 | 76.4 ± 12.1 |.005 | 3).038 4).026

    PMID 33565706 · one of two readings recorded this

  • gastric emptying Tmax (13C-sodium acetate breath test)

    increases, p = 0.005

    Tmax (min) | 19.29 ± 7.3 | 21.25 ± 7.7 | 25.00 ± 7.4 | 41.25 ± 15.8 |.005 | 3).003 4).005 5).019

    PMID 33565706 · one of two readings recorded this

  • plasma aGLP-1 iAUC 0-180 min

    increases, p = 0.002

    iAUC (0‐180 min) (pmol x min/L) | −43.9 ± 210.2 | 162.3 ± 290.0 | 149.9 ± 297.6 | 396.0 ± 342.3 |.002 | 1).011 2).013 3).001 6).036

    PMID 33565706 · one of two readings recorded this

  • plasma aGLP-1 iAUC 0-60 min

    increases, p = 0.002

    iAUC (0‐60 min) (pmol x min/L) | 8.0 ± 83.9 | 151.7 ± 114.4 | 235.2 ± 152.0 | 325.4 ± 200.8 |.002 | 1).016 2).001 3).001 5).03

    PMID 33565706 · one of two readings recorded this

  • plasma aGLP-1 iCmax

    increases, p = 0.001

    iCmax (pmol/L) | 2.4 ± 2.0 | 7.2 ± 4.2 | 9.1 ± 3.4 | 11.5 ± 5.8 | <.001 | 1).001 2)<.001 3)<.001

    PMID 33565706 · one of two readings recorded this

  • plasma aGLP-1 Tmax

    no effect

    Tmax (min) | 34.3 ± 64.6 | 31.3 ± 28.2 | 30.0 ± 47.4 | 27.5 ± 8.7 | NS

    PMID 33565706 · one of two readings recorded this

  • plasma CCK iAUC 0-180 min

    increases, p = 0.004

    iAUC (0‐180 min) (pmol x min/L) | −30.6 ± 56.0 | −32.4 ± 142.2 | 29.4 ± 101.1 | 92.9 ± 177.6 |.004 | 2).028 3).007 5).048

    PMID 33565706 · one of two readings recorded this

  • plasma CCK iAUC 0-60 min

    increases, p = 0.001

    iAUC (0‐60 min) (pmol x min/L) | −1.9 ± 18.2 | 4.4 ± 45.3 | 58.9 ± 53.8 | 129.8 ± 101.9 |.001 | 2).001 3).001 4).016 5).001 6).012

    PMID 33565706 · one of two readings recorded this

  • plasma CCK iCmax

    increases, p = 0.011

    iCmax (pmol/L) | 0.6 ± 0.5 | 1.5 ± 1.2 | 3.6 ± 2.9 | 4.9 ± 3.7 |.011 | 1).024 2).003 3).002 4).028 5).003

    PMID 33565706 · one of two readings recorded this

  • plasma CCK Tmax

    no effect

    Tmax (min) | 57.0 ± 62.1 | 21.3 ± 31.6 | 15.0 ± 0.0 | 20.0 ± 7.4 | NS

    PMID 33565706 · one of two readings recorded this

  • plasma cholecystokinin iAUC 0-60 min, 0-180 min and iCmax after 10, 25, 50 g erythritol versus placebo

    Not recorded as a finding: Node plasma-cholecystokinin exists, but the sentences say only 'statistically significant difference' with no direction word; direction is carried by the table

    Pairwise comparison revealed a statistically significant difference for 25 g erythritol versus placebo, 50 g erythritol versus placebo, 10 versus 25 g erythritol, 10 versus 50 g erythritol and 25 versus 50 g erythritol.

    PMID 33565706 · one of two readings recorded this

  • plasma GIP iAUC 0-180 min

    no effect

    iAUC (0‐180 min) (pmol x min/L) | −4893.9 ± 5873.0 | −8033.4 ± 5893.7 | −1036.5 ± 17 308.1 | −7006.8 ± 7383.5 | NS

    PMID 33565706 · one of two readings recorded this

  • plasma GIP iAUC 0-60 min

    no effect

    iAUC (0‐60 min) (pmol x min/L) | −970.9 ± 1440.5 | −1744.9 ± 1872.8 | −3222.6 ± 7365.1 | −1050 ± 1984.4 | NS

    PMID 33565706 · one of two readings recorded this

  • plasma GIP, motilin, insulin and glucagon iAUC, iCmax and iCmin

    no effect

    Not recorded as a finding: nodes plasma-gip and plasma-glucagon require sampling after a mixed-nutrient drink (glucagon also after an amino-acid preload) and stimulated-postprandial-insulin requires the amino-acid preload; motilin has no node; this trial gave erythritol in water

    No effect of erythritol treatment on plasma GIP, motilin, insulin and glucagon concentrations was found: the values of iAUC 0‐60 min, iAUC 0‐180 min, iCmax and iCmin did not show any overall statistically significant differences (GIP/motilin: Figure 1D,E and Table 1; insulin/glucagon: Figure 2B,C and Table 2).

    PMID 33565706 · one of two readings recorded this

  • plasma glucagon iAUC 0-180 min

    no effect

    iAUC (0‐180 min) (pmol × min/L] | −45.0 ± 294.3 | −73,8 ± 204.3 | −13.4 ± 279.0 | 42.4 ± 237.1 | NS

    PMID 33565706 · one of two readings recorded this

  • plasma glucagon iAUC 0-60 min

    no effect

    iAUC (0‐60 min) (pmol × min/L] | 8.6 ± 83.6 | 10.0 ± 53.8 | 16.1 ± 105.3 | 11.3 ± 67.4 | NS

    PMID 33565706 · one of two readings recorded this

  • plasma glucose concentration

    no effect

    Erythritol treatment did not lead to an increase in plasma glucose concentrations

    PMID 33565706 · one of two readings recorded this

  • plasma glucose concentrations after erythritol

    Not recorded as a finding: One-sided negation ('did not lead to an increase') is not no_effect, and the glucose nodes require a glucose load or fasting sample

    Erythritol treatment did not lead to an increase in plasma glucose concentrations.

    PMID 33565706 · one of two readings recorded this

  • plasma glucose iAUC 0-180 min

    no effect

    iAUC (0‐180 min) (mmol × min/L) | −8.46 ± 6.72 | −14.3 ± 45.6 | −48.1 ± 93.8 | −29.5 ± 37.2 | NS

    PMID 33565706 · one of two readings recorded this

  • plasma glucose iAUC 0-60 min

    no effect

    iAUC (0‐60 min) (mmol × min/L) | −3.32 ± 4.56 | −6.56 ± 17.18 | −13.38 ± 29.66 | −8.13 ± 9.99 | NS

    PMID 33565706 · one of two readings recorded this

  • plasma glucose iCmin

    decreases, p = 0.015

    iCmin (mmol/L] | −0.17 ± 0.08 | −0.41 ± 0.53 | −0.54 ± 0.76 | −0.38 ± 0.24 |.015 | 1).042

    PMID 33565706 · one of two readings recorded this

  • plasma insulin iAUC 0-180 min

    no effect

    iAUC (0‐180 min) (μmol × min/L) | −31.8 ± 169.8 | −86.5 ± 165.4 | −122.8 ± 197.6 | −80.8 ± 261.7 | NS

    PMID 33565706 · one of two readings recorded this

  • plasma insulin iAUC 0-60 min

    no effect

    iAUC (0‐60 min) (μmol × min/L) | 0.75 ± 68.0 | −40.5 ± 63.4 | −33.6 ± 72.4 | 0.84 ± 89.4 | NS

    PMID 33565706 · one of two readings recorded this

  • plasma insulin iAUC and iCmax after erythritol versus placebo, plasma motilin, PYY

    no effect, no overall statistically significant differences for insulin and motilin

    Not recorded as a finding: stimulated-postprandial-insulin requires an intragastric amino-acid preload followed by a mixed drink, not stated here; no node for motilin or PYY

    No effect of erythritol treatment on plasma GIP, motilin, insulin and glucagon concentrations was found: the values of iAUC 0‐60 min, iAUC 0‐180 min, iCmax and iCmin did not show any overall statistically significant differences (GIP/motilin: Figure 1D,E and Table 1; insulin/glucagon: Figure 2B,C and Table 2).

    PMID 33565706 · one of two readings recorded this

  • plasma motilin iAUC 0-180 min

    no effect

    iAUC (0‐180 min) (pg x min/mL) | −5419 ± 8547 | −2381 ± 17 475 | −349 ± 15 857 | 5539 ± 19 957 | NS

    PMID 33565706 · one of two readings recorded this

  • plasma motilin iAUC 0-60 min

    no effect

    iAUC (0‐60 min) (pg x min/mL) | −750.3 ± 4302.5 | 881 ± 6306 | 2190 ± 6024 | 3143 ± 6268 | NS

    PMID 33565706 · one of two readings recorded this

  • plasma PYY iAUC 0-180 min

    increases, p = 0.001

    iAUC (0‐180 min) (pmol x min/L) | −3359 ± 4219 | 578 ± 5009 | −42.7 ± 7948 | 15 628 ± 7773 | <.001 | 3).002 5)<.001 6)<.001

    PMID 33565706 · one of two readings recorded this

  • plasma PYY iAUC 0-60 min

    increases, p = 0.001

    iAUC (0‐60 min) (pmol x min/L) | −238.3 ± 1200.0 | 568.5 ± 1550.5 | 1167.6 ± 1906.7 | 3935.0 ± 2264.0 |.001 | 3).025 5).001 6).024

    PMID 33565706 · one of two readings recorded this

The whole record — 754 rows